SBIR/STTR Research Award

SNET2-Based Photodynamic Occlusion of Ocular Vessels

Award identifier e7696ee65d1906a9359c9006e521e5c353424d21fd9cdeb8eca117fb54b9bd1fAwarding agency Department of Health and Human Services

Award amount

$677,110

Program and phase

SBIR · Phase II

Award year

1997

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Pdt Pharmaceuticals
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Neovascularization is associated with two ocular disorders, macular degeneration and diabetic retinconditions are high profile disorders that have significant association with visual impairments andare only preventative measures taken by clinicians to slow the progression of the diseases. No curatfound despite intensive research. Later photocoagulation is the current methodology for the treatmenin the eye. However, normal tissues and vessels adjacent to the targeted site are irreversibly damagheat. The ideal therapeutic modality would provide for highly selective and finely controlled destrublood vessels and/or area while minimizing damage to adjacent normal tissues. It is the aim of thispreliminary investigations on the use of photodynamic therapy (PDT) using tin ethyl etiopurpurin (Snof neovascularization in the eye. PDT holds promise as a more efficacious treatment modality than thphotocoagulation due to its low energy, non thermal light activation of a photosensitizer leading todestruction, thus sparing normal tissues. If the data resulting from Phase I studies looks efficaciodevelopment can be pursued in Phase II to determine optimum combinations of photosensitizer and lighmaximum therapeutic benefit.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.